Clinical trial
Early Feasibility Study (EFS) of the Cardiac Implants Percutaneous Ring Annuloplasty System for the Treatment of Functional Tricuspid Regurgitation
NCT04890821 is registered in ClinicalTrials.gov with Cardiac Implants LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early Feasibility Study (EFS) of the Cardiac Implants Percutaneous Ring Annuloplasty System for the Treatment of Functional Tricuspid Regurgitation
- Lead sponsor
- Cardiac Implants LLC
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- December 31, 2021
- Completion date
- September 30, 2027
- Enrollment
- 15 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
tricuspid regurgitation functional